Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cognitive Dysfunction × Ramipril × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 1 Cognitive Dysfunction 1 Brain Neoplasms 1

Interventions

mazdutide 1 enzalutamide 1 Standard of Care 1 Ramipril 1 Prednisone 1 Low-Level Light Therapy 1 Hormones 1 Gonadotropin-Releasing Hormone 1 Exercise 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03475186 2026-03-13

Testing Ramipril to Prevent Memory Loss in People With Glioblastoma

Wake Forest University Health Sciences

Phase 2 Completed

75 enrolled 47 charts

Brain Neoplasms, Glioblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡